Frank X Leonard $NVCR SEC Form 4 Insider Trading

Frank X Leonard has filed a total of 49 insider trades in $NVCR since 2021. Their most recent trade was a sale of 598 shares, made on Nov 01, 2024. Their largest trade was a sale of 7,826 shares, made on Jan 05, 2023. We estimate that they now own 161,236 shares of $NVCR, worth an estimated $5.3 million.

Insider Trading at $NVCR

There have been a total of 151 insider trades reported at $NVCR since 2021, with 4,974 shares purchased and 542,412 shares sold. The most active insider traders in $NVCR stock have been Frank X Leonard, Frank X Leonard, and Ashley Cordova. The most recent trade was a sale of 44 shares reported by Mukund Paravasthu (Chief Operating Officer), made on Nov 02, 2024.

$NVCR Executives and Stock Owners with Insider Trades

• Frank X Leonard, Chief Development Officer

• Frank X Leonard, President, CNS Cancers US

• Ashley Cordova, Chief Financial Officer

• Asaf Danziger, Chief Executive Officer

• Wilhelmus Cm Groenhuysen, Chief Operating Officer

• Pritesh Shah, Chief Commercial Officer

• Ely Benaim, Chief Medical Officer

• William Patrick Burke, Chief Human Resources Officer

• Pritesh Shah, Chief Growth Officer

• Frank X Leonard, EVP, Pres., Novocure Oncology

• Uri Weinberg, Chief Science Officer

• Todd Christopher Longsworth, General Counsel

• William F Doyle, Executive Chairman

• Mukund Paravasthu, Chief Operating Officer

• Michal Nath Puri, Chief Human Resources Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.